Ehong Gu
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Ehong Gu is currently the Chief Financial & Accounting Officer at LianBio.
Previously, she worked as the Assistant Vice President-Finance at CStone Pharmaceuticals Co. Ltd. from 2019 to 2021.
She holds an MBA from Rotman School of Management and an undergraduate degree from Shanghai University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIANBIO -.--% | 19/12/2023 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LIANMEDICAL | Directeur Financier/CFO | 19/12/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| CSTONE PHARMACEUTICALS | Corporate Officer/Principal | 01/01/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai University
Shanghai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CStone Pharmaceuticals Co. Ltd.
CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
LianBio
LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national